The clinical significance of plasmatic amyloid Aß40 peptide levels in Alzheimer’s disease patients treated with galantamine.

24/11/2008

From Modrego P., Monleón I., Sarasa M. to 24/11/2008

Reference: American Journal of Alzheimer’s Disease and Other Dementia 23, 286-290